{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:55:52Z","timestamp":1793051752023,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.reprotox.2021.05.006","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T11:52:58Z","timestamp":1621252378000},"page":"51-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["First trimester naproxen exposure and outcome of pregnancy \u2013 A German case series"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5720-7721","authenticated-orcid":false,"given":"Stefanie","family":"Hultzsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2046-0074","authenticated-orcid":false,"given":"Wolfgang","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Padberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Katrin","family":"Fietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9001-0525","authenticated-orcid":false,"given":"Christof","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Dathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.reprotox.2021.05.006_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219095","article-title":"The French Pregnancy Cohort: Medication use during pregnancy in the French population","volume":"14","author":"Berard","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.reprotox.2021.05.006_bib0010","doi-asserted-by":"crossref","first-page":"404 e1","DOI":"10.1016\/j.ajog.2014.03.054","article-title":"Case-control analysis of maternal prenatal analgesic use and cardiovascular malformations: Baltimore-Washington Infant Study","volume":"211","author":"Marsh","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.reprotox.2021.05.006_bib0015","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ajog.2005.02.100","article-title":"Use of over-the-counter medications during pregnancy","volume":"193","author":"Werler","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.reprotox.2021.05.006_bib0020","series-title":"Arzneiverordnungs-Report 2020","author":"Schwabe","year":"2020"},{"issue":"10","key":"10.1016\/j.reprotox.2021.05.006_bib0025","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00228-019-02712-2","article-title":"Risk estimation of fetal adverse effects after short-term second trimester exposure to non-steroidal anti-inflammatory drugs: a literature review","volume":"75","author":"Dathe","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.reprotox.2021.05.006_bib0030","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/adc.54.12.942","article-title":"Persistent pulmonary hypertension and abnormal prostaglandin E levels in preterm infants after maternal treatment with naproxen","volume":"54","author":"Wilkinson","year":"1979","journal-title":"Arch. Dis. Child."},{"issue":"8194","key":"10.1016\/j.reprotox.2021.05.006_bib0035","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(80)92026-7","article-title":"Naproxen levels in preterm infants after maternal treatment","volume":"2","author":"Wilkinson","year":"1980","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.reprotox.2021.05.006_bib0040","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1179\/146532806X120345","article-title":"Renal tubular dysgenesis with atypical histology and in-utero exposure to naproxen sodium","volume":"26","author":"Koklu","year":"2006","journal-title":"Ann. Trop. Paediatr."},{"issue":"3","key":"10.1016\/j.reprotox.2021.05.006_bib0045","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1542\/peds.107.3.519","article-title":"Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn","volume":"107","author":"Alano","year":"2001","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.reprotox.2021.05.006_bib0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2000-9271","article-title":"Persistent pulmonary hypertension after maternal naproxen ingestion in a term newborn: a case report","volume":"17","author":"Talati","year":"2000","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/j.reprotox.2021.05.006_bib0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.reprotox.2015.08.002","article-title":"Reversible oligohydramnios in the second trimester of pregnancy in two patients with long-term diclofenac exposure","volume":"58","author":"Scherneck","year":"2015","journal-title":"Reprod. Toxicol."},{"issue":"4","key":"10.1016\/j.reprotox.2021.05.006_bib0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0890-6238(01)00137-X","article-title":"Nonsteroidal anti-inflammatory drugs in early pregnancy","volume":"15","author":"Ericson","year":"2001","journal-title":"Reprod. Toxicol."},{"issue":"3","key":"10.1016\/j.reprotox.2021.05.006_bib0065","doi-asserted-by":"crossref","first-page":"228 e1","DOI":"10.1016\/j.ajog.2011.11.019","article-title":"S. National Birth Defects Prevention Study, Nonsteroidal antiinflammatory drug use among women and the risk of birth defects","volume":"206","author":"Hernandez","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.reprotox.2021.05.006_bib0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.annepidem.2017.09.003","article-title":"S. National Birth Defects Prevention Study, Risk comparison for prenatal use of analgesics and selected birth defects, National Birth Defects Prevention Study 1997-2011","volume":"27","author":"Interrante","year":"2017","journal-title":"Ann. Epidemiol."},{"issue":"8","key":"10.1016\/j.reprotox.2021.05.006_bib0075","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/1471-0528.12192","article-title":"Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study","volume":"120","author":"Nezvalova-Henriksen","year":"2013","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.reprotox.2021.05.006_bib0080","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/bdrb.20085","article-title":"Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study","volume":"77","author":"Ofori","year":"2006","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"issue":"11","key":"10.1016\/j.reprotox.2021.05.006_bib0085","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3899\/jrheum.120453","article-title":"Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy","volume":"39","author":"Daniel","year":"2012","journal-title":"J. Rheumatol."},{"issue":"7281","key":"10.1016\/j.reprotox.2021.05.006_bib0090","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.322.7281.266","article-title":"Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study","volume":"322","author":"Nielsen","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.reprotox.2021.05.006_bib0095","first-page":"1","article-title":"EUROCAT Guide 1.4: instruction for the registration of congenital anomalies","author":"EUROCAT - European Surveillance of Congenital Anomalies","year":"2019","journal-title":"JRC-EUROCAT Central Registry"},{"key":"10.1016\/j.reprotox.2021.05.006_bib0100","series-title":"Prevalence per 10,000 births. All Anomalies - 2011 to 2018","article-title":"Prevalence charts and tables","author":"EUROCAT","year":"2020"},{"issue":"3","key":"10.1016\/j.reprotox.2021.05.006_bib0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0890-6238(03)00012-1","article-title":"Maternal drug use in early pregnancy and infant cardiovascular defect","volume":"17","author":"Kallen","year":"2003","journal-title":"Reprod. Toxicol."},{"issue":"7431","key":"10.1016\/j.reprotox.2021.05.006_bib0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/bmj.328.7431.109","article-title":"Danish group reanalyses miscarriage in NSAID users","volume":"328","author":"Nielsen","year":"2004","journal-title":"BMJ (Clinical research ed.)"},{"issue":"15","key":"10.1016\/j.reprotox.2021.05.006_bib0115","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1503\/cmaj.110454","article-title":"Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion","volume":"183","author":"Nakhai-Pour","year":"2011","journal-title":"CMAJ : Can. Med. Assoc. J. = journal de l\u2019Association medicale canadienne"},{"issue":"5","key":"10.1016\/j.reprotox.2021.05.006_bib0120","doi-asserted-by":"crossref","first-page":"E177","DOI":"10.1503\/cmaj.130605","article-title":"Fetal exposure to nonsteroidal anti-inflammatory drugs and spontaneous abortions","volume":"186","author":"Daniel","year":"2014","journal-title":"CMAJ : Can. Med. Assoc. J. = journal de l\u2019Association medicale canadienne"},{"issue":"1","key":"10.1016\/j.reprotox.2021.05.006_bib0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/AOG.0b013e3182595671","article-title":"Periconceptional over-the-counter nonsteroidal anti-inflammatory drug exposure and risk for spontaneous abortion","volume":"120","author":"Edwards","year":"2012","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.reprotox.2021.05.006_bib0130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/pds.3744","article-title":"Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome","volume":"24","author":"Wacker","year":"2015","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"1","key":"10.1016\/j.reprotox.2021.05.006_bib0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.reprotox.2008.06.006","article-title":"Statistical methods for estimating the probability of spontaneous abortion in observational studies--analyzing pregnancies exposed to coumarin derivatives","volume":"26","author":"Meister","year":"2008","journal-title":"Reprod. Toxicol."},{"issue":"5","key":"10.1016\/j.reprotox.2021.05.006_bib0140","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/pds.4710","article-title":"Multistate methodology improves risk assessment under time-varying drug intake-a new view on pregnancy outcomes following coumarin exposure","volume":"28","author":"Bluhmki","year":"2019","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"Suppl 3","key":"10.1016\/j.reprotox.2021.05.006_bib0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2106\/JBJS.H.01573","article-title":"How to design a good case series","volume":"91","author":"Kooistra","year":"2009","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.reprotox.2021.05.006_bib0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.reprotox.2016.11.019","article-title":"Who seeks Teratology Information Service\u2019s advice? Assessing the risk of selection bias in observational cohort studies on drug risks in pregnancy","volume":"67","author":"Beck","year":"2017","journal-title":"Reprod. Toxicol."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089062382100071X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089062382100071X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:54:25Z","timestamp":1760190865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089062382100071X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":30,"alternative-id":["S089062382100071X"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2021.05.006","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First trimester naproxen exposure and outcome of pregnancy \u2013 A German case series","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2021.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}